Skip to content
Trial Eligibility
Menu

Ulcerative Colitis Clinical Trials near Seattle, WA

18 studies for Ulcerative Colitis are recruiting at 24 sites within 50 miles of Seattle, Washington, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near Seattle.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Ulcerative Colitis studies enrolling near Seattle

Showing 18 studies, nearest first.
  1. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

    NCT05076175

    • Phase 2/3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: Seattle Children's Hospital (Seattle, WA); MultiCare Health System (Tacoma, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  2. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    NCT07012395

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Site 004 (Seattle, WA); Site 019 (Tacoma, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

    NCT06315179

    • Observational
    • Ages 6 to 21 years
    • Sex: All

    Nearest site: Seattle Children's Hospital (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  4. Familial Inflammatory Bowel Disease Early Risk

    NCT07791862

    • Observational
    • Ages 0 to 55 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Seattle Children's Hospital (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Mirador Therapeutics Selected Site (Bellevue, WA); Mirador Therapeutics Selected Site (Silverdale, WA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  6. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Washington Gastroenterology - Bellevue /ID# 283966 (Bellevue, WA); Washington Gastroenterology - Tacoma /ID# 284143 (Tacoma, WA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07845487

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Site US-021 (Bellevue, WA); Site US-029 (Tacoma, WA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: GI Alliance (Bellevue, WA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07184996

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest site: GI Alliance - Bellevue - Site Number: 8400143 (Bellevue, WA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

    NCT07186101

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Washington Gastroenterology - Bellevue (Bellevue, WA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

    NCT06095128

    • Phase 4
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Washington Gastroenterology- GIA (Tacoma, WA)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

    NCT06398626

    • Observational
    • Ages 18 to 64 years
    • Sex: All

    Nearest site: Washington Gastroenterology (Tacoma, WA)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

    NCT06636656

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Digestive Health Specialists (Tacoma, WA)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

    NCT06651281

    • Phase 3
    • Ages Any age
    • Sex: All

    Nearest site: Washington Gastroenterology - Tacoma ( Site 0295) (Tacoma, WA)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

    NCT06937086

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Washington Gastroenterology - Tacoma (Tacoma, WA)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07196748

    • Phase 3
    • Ages 12 years and older
    • Sex: All

    Nearest site: GI Alliance Tacoma (Tacoma, WA)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

    NCT07415044

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Washington Gastroenterology - Tacoma (Tacoma, WA)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07577856

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: GI Alliance Tacoma (Tacoma, WA)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Ulcerative Colitis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.